African Traditional Herbal Research Clinic STD's ... - Blackherbals.com

African Traditional Herbal Research Clinic
Volume 6, Issue 10 NEWSLETTER October 2011
FEATURED ARTICLES
Gay Vaccine Experiments and the American
(Not African) Origin of AIDS
By Alan Cantwell, MD
September 1, 2011
Ever since the AIDS epidemic became official in June
1981, there have been rumors that AIDS is a man-made
disease. Although this theory has been discredited by
"scientific consensus," there is evidence linking the
outbreak of this new disease to a vaccine experiment
conducted on gay men in New York City, as well as in
other U.S. cities, between 1978 and 1981.
The first epidemic cases of AIDS in America were
uncovered exclusively in young, previously healthy, and
mostly white gay men in Manhattan in 1979. The cause
was unknown until 1984 when a virus, later named HIV
(human immunodeficiency virus), was accepted as the
infectious agent. How a sexually transmitted disease
(STD), purportedly originating in Africa, was
transferred into a so-called "gay disease" in New York
City was left unexplained, except for preposterous stories
like the gay Canadian airline steward Gaetan Dugas, who
was demonized in the media and tabloids as "the man
who brought AIDS to America."
THE GAY VACCINE
EXPERIMENTS BEFORE AIDS (1978-1981)
Beginning in 1974, workers in a bloodmobile provided
by the New York Blood Center in Manhattan began
soliciting 8,906 gay men for a hepatitis B vaccine
research study (Koblin et al, 1992). Over the next few
years more that 10,000 blood samples were donated by
gays willing to participate in the development of a
vaccine that might prevent hepatitis B. This viral disease
was an STD disproportionately affecting sexually-active
homosexuals.
The AIDS epidemic in the U.S. directly traces back to
this government-sponsored vaccine experiment!
Eventually, 1,083 gay men were recruited to be injected
with an experimental hepatitis B vaccine at the New York
Blood Center. In the months before the actual experiment
began, the vaccine underwent preliminary testing for
safety and immune response on two hundred physicians
at New York Medical Center, as well as on twenty-
eight employees of Merck & Co, which made the
vaccine.
The first group of men in the actual trial was
inoculated in November 1978. The experiment was
confidential. Each man was given an anonymous
identification number, which would be the only way
they could be identified by the investigators. Each man
got an initial dose of vaccine, then a repeat one
month after, and a final inoculation six months later.
All were asked to donate blood samples for two years
after the three injections. Over a period of months,
all 1,083 men would be injected. Half the men were
given the experimental vaccine; the other half would
serve as the control group and were given useless
placebo injections. In this double-blind study, neither
the men nor the investigators knew who was getting the
vaccine or the placebo.
This experiment ended in September 1980. The success
rate in preventing hepatitis B in the group receiving the
vaccine was 92.3%. Additional experimental hep B
vaccine trials, all using gay men as the guinea pig, were
conducted in 1979 and 1980 in Chicago, Los Angeles,
San Francisco, Denver and St. Louis.
In May 1981, the men in the placebo group (who did
not receive the vaccine) at the Blood Center were
offered a chance to take the vaccine. As a result, 270
men were inoculated with the series of three shots and
were asked to donate additional blood samples for two
more years. Because men in the vaccinerecipient
group and the placebo group were now both
inoculated with the vaccine, it would no longer be
possible to compare the two groups in terms of future
HIV rates. Because the experiment was confidential
and anonymous, the fate of the individual men in terms
of acquiring HIV/AIDS in the future could never be
ascertained. In June 1981, after 41 cases of a new
disease in homosexuals were reported to the Centers for
Continued on page 5
-4- Traditional African Clinic – October 2011